Assessing cancer patients' trust in their oncologist: development and validation of the Trust in Oncologist Scale (TiOS) by M. A. Hillen et al.
ORIGINAL ARTICLE
Assessing cancer patients' trust in their oncologist:
development and validation of the Trust in Oncologist
Scale (TiOS)
M. A. Hillen & C. C. E. Koning & J. W. Wilmink & J. H. G. Klinkenbijl & E. H. Eddes &
B. L. Kallimanis-King & J. C. J. M. de Haes & E. M. A. Smets
Received: 16 February 2011 /Accepted: 13 September 2011 /Published online: 27 September 2011
# The Author(s) 2011. This article is published with open access at Springerlink.com
Abstract
Purpose The aim of this study was to develop and validate
the Trust in Oncologist Scale (TiOS), which aims to
measure cancer patients' trust in their oncologist. Structure,
reliability and validity were examined.
Methods Construction of the TiOS was based on a
multidimensional theoretical framework. Cancer patients
were surveyed within a week after their consultation. Trust,
satisfaction, trust in health care, self-reported health and
background variables were assessed. Dimensionality, inter-
nal consistency, test–retest reliability and construct validity
were investigated.
Results Data of 423 patients were included (response rate =
65%). After item reduction, the TiOS included 18 items.
Trust scores were high. Exploratory factor analysis sug-
gested one-dimensionality. Confirmatory factor analysis
nevertheless indicated a reasonable fit of our four-
dimensional theoretical model, distinguishing competence,
fidelity, honesty and caring. Internal consistency and test–
retest reliabilities were high. Good construct validity was
indicated by moderate correlations of trust (TiOS) with
satisfaction, trust in health care, willingness to recommend
and number of consultations with the oncologist. Explor-
atory analyses suggested significant correlations of trust
with ethnicity and age.
Conclusions The TiOS reliably and validly assesses cancer
patients' trust in their oncologist. The questionnaire can be
employed in both clinical practice and future research of
cancer patients' trust.
Keywords Trust . Cancer . Oncology . Communication .
Doctor–patient relationships . Psychometrics
Introduction
Patients' trust in their physician is considered essential for
good quality and effective medical care [1]. Several
definitions of trust exist, but they invariably include the
aspect of patients' vulnerability [2, 3]. Hall et al. [4]
contend that to trust, patients have to optimistically accept
their vulnerable situation and believe that the physician will
care for their interests. The significance of trust is reflected
in an abundance of analytical essays published on the topic
(e.g. [5–8]). Yet, empirical research has long lagged behind
in both quantity and quality [7]. Over the past decade,
increased empirical attention has resulted in more knowl-
edge on patients' trust. Evidence suggests that trusting
patients are more satisfied [9, 10], more adherent [11–13],
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more involved in decision making [11] and less inclined to
request a second opinion [10, 14]. Research papers
reporting that trust is not associated with presumed
beneficial effects, or that strong trust is associated with
harmful outcomes, are very scarce. This might, however, be
the result of a publication bias [15].
Most of the present evidence on patients' trust originates
from correlational research performed in primary care.
Within this setting, three different questionnaires have been
developed to assess patients' interpersonal trust in their
physician [10, 16, 17].
The ‘Trust in Physician Scale’ [16] was developed first,
and measures patients' trust in their primary care provider. It
assesses patients' perception of the physician's (1) ‘depend-
ability’, i.e. looking out for the patient's best interest, (2)
skills and knowledge and (3) provision of reliable informa-
tion. The ‘Patient Trust Scale’ [17] was constructed
subsequently to incorporate changes in the healthcare
system, specifically the transition to managed care. Al-
though based on the ‘Trust in Physician Scale’, the scale
additionally took into account cost restraints faced by the
physician.
The ‘Physician Trust Scale’ [10] was developed most
recently and is currently the most widely used instrument to
assess patients' trust [2]. The original theoretical model by
Hall et al. encompassed five trust dimensions: (1) Fidelity,
the physician's pursuit of the patients' interests; (2)
Competence, the physician's medical and interpersonal
skills; (3) Honesty, telling the truth and avoiding intentional
falsehoods; (4) Confidentiality, the physician's adequate
handling of sensitive information and (5) Global trust, ‘the
irreducible soul of trust, or aspects that combine elements
from some or all of the separate dimensions’ ([10]; p.298).
The ‘Confidentiality’ dimension was removed after pilot
testing, because it lacked relevance to patients. Moreover,
empirical data did not support the multidimensional model,
but rather suggested that patients' trust was best regarded as
one-dimensional.
As all three existing scales were developed in the
primary care setting, it is unclear to what extent they
accurately assess trust in specific patient populations.
Aspects of trust irrelevant to primary care patients could
be significant to patients with specific diseases or vice versa
[10]. Confidentiality, for example might become more
significant for trust in more severe or sensitive circum-
stances, such as HIV/AIDS or genetics.
For cancer patients, different elements might be relevant
for trust than for primary care patients. When confronted
with a cancer diagnosis, trust in the oncologist appears to
be essential [8, 18]. This necessity may be stronger than in
most other conditions, because of the life-threatening nature
of cancer. Patients need to cope with a severe diagnosis and
intensive treatment which strongly impacts on their daily
lives and future. Moreover, they need to grasp complex
information and make difficult medical decisions. Conse-
quently, cancer patients' constructions and explanations of
trust might differ from trust in other patient populations.
Presently, no measure of trust for oncology patients
exists, preventing advances in systematic research of
predictors and correlates of cancer patients' trust. Therefore,
the aim of this study was to develop a questionnaire which
reliably captures cancer patients' trust in their oncologist,
the Trust in Oncologist Scale (TiOS), and to assess its




In open-ended qualitative interviews with cancer patients
[18], we identified aspects defining patients' trust in their
oncologist. This resulted in the development of an initial
conceptual five-dimensional model of cancer patients' trust,
reflecting four of the dimensions of Hall et al. [10], i.e.
Competence, Fidelity, Confidentiality and Honesty. In
addition, patients' accounts of trust obtained in our
qualitative study resulted in the construction of a fifth
dimension, which we labelled ‘Caring’. This dimension,
added because the existing dimensions did not fully capture
patients' constructions of trust, refers to the oncologist's
expression of involvement, sympathy and attention to the
patient [18].
Item collection and development were performed by two
of the authors (MH and ES, both researchers), based on the
five-dimensional model. In addition to all ten items of the
original ‘Physician Trust Scale’, appropriate items were
selected from other trust measures [10, 16, 19, 20] so that at
least three items per dimension were included. When not
enough items were available, new items were constructed
by the first author, based on the results of our qualitative
study. Where possible, patients' original wording was used.
Newly constructed items were discussed among two of the
authors (MH and ES, both researchers), following guide-
lines for item construction [21]. Existing items phrased in
English were translated into Dutch following a forward–
backward procedure, involving two forward and two
backward translators. The two most general items of Hall
et al.'s ‘Global Trust’ dimension were added to the new
scale, as overall trust assessments. To allow for variation in
responses to the two items, they were modelled as single
indicator variables. Item collection resulted in 33 candidate
items1.
1 Readers interested in all candidate items, please contact the authors.
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Wording, relevance and difficulty of items were tested in
a pilot sample of 12 patients visiting the Department of
Medical Oncology of an academic hospital, using guide-
lines for cognitive interviewing [22]. Patients commented
upon the wording and relevance for trust (content validity)
of each item, and on possible relevant additions to the
questionnaire. Consequently, minor adjustments were
made. No items were removed or added.
Patients and procedure
Cancer patients were recruited from three departments of an
academic hospital: Medical Oncology (MO), Radiation
Oncology (RO) and Surgery (SG) and from the Department
of Surgery at a regional hospital (SR). Inclusion criteria
were (1) >18 years of age, (2) a diagnosis of malignant
disease and (3) sufficient mastery of the Dutch language.
Patients were either in treatment or received regular
checkups. According to rules of thumb, a sample size of
10–15 participants per variable is required to perform
Confirmatory Factor Analysis (CFA) [23]. After item
reduction, we expected to include approximately 20 items
in the definitive scale. Because of our intention to split the
data into a training and a test set, a minimum of 400
patients (200 for each data set) was required. Two different
recruitment procedures were adopted, depending on depart-
ment policies and preferences: the researcher approached
patients either directly by mail within 3 days after their
consultation with the oncologist (RO and SG) or after
consent was obtained by their attending oncologist (SR and
MO). All patients received an introductory letter and the
questionnaire, along with a form to indicate refusal to
participate. Reminders were sent to non-responders after 3–
4 weeks if possible (RO and SR). A subset of 77 patients
was asked to complete the questionnaire again 3–4 weeks
after the first time, to assess test–retest reliability. This time
interval was expected to be long enough to avoid memory
bias and short enough to prevent changes in patients' levels
of trust (e.g. as a result of new consultations with their
oncologist).
Materials
Trust in Oncologist Scale
The initial version of the TiOS contained 33 candidate
items. All items consisted of a proposition in the third-
person singular, to be answered on a 5-point Likert scale
(‘strongly disagree’=1 to ‘strongly agree’=5). Ten items
were negatively phrased. An example of a question is
“Your doctor strongly cares about your health”. An overall
trust score (range 1–5), was obtained by averaging the
responses, with higher scores indicating higher trust.
Background characteristics
Socio-demographics assessed were patients' age, gender,
marital status, education level, ethnicity and religion (‘do
you consider yourself religious?’). Disease characteristics
included time since diagnosis, cancer site and treatments
undergone. Questions about the relationship with the
caregivers included the number of different oncologists
patients had seen, and the number of consultations with
their present oncologist.
Satisfaction with physician
Satisfaction with the previous three consultations with the
oncologist was measured by the five-item Patient Satisfac-
tion Questionnaire (PSQ) [24]. Responses were marked on
a visual analogue scale (‘not at all satisfied’=1 to
‘extremely satisfied’=10). Internal consistency for the
PSQ was strong (Cronbach's α=0.89). Additionally, one
question assessed whether patients would recommend their
oncologist to others, rated on a 5-point Likert scale
(‘strongly disagree’=1, to ‘strongly agree’=5).
Trust in Dutch health care system
Patients' general trust in the Dutch health care system was
assessed with one item, adapted from a trust in Dutch health
care questionnaire [19]. Patients were asked: ‘How much
trust do you have in the current Dutch health-care system’,
rated on a 5-point Likert scale (‘very little trust’=1 to ‘a
great deal of trust’=5).
Self-reported health status
Self-reported physical and mental health status were
measured using a Dutch translation [25] of the 12-item
short-form (SF-12) of the Medical Outcomes Study [26].
Internal consistency was strong for both the physical (α=
0.89) and the mental (α=0.89) component.
Analyses
Unless otherwise indicated, all analyses were performed
using SPSS 16 (SPSS Inc., Chicago, IL, USA). Data of
participants with more than 25% missing overall or on the
TiOS specifically were completely removed. Remaining
missing values on the TiOS were replaced using expecta-
tion maximization (EM) [27]. Regression analysis was
performed to check whether the different acquisition
procedures, i.e. via the researcher or via the oncologist,
might have induced bias.
To analyse dimensionality, the data was randomly split
in two halves: a training set and a test set. First, the original
Support Care Cancer (2012) 20:1787–1795 1789
33-item 5-factor model was tested on the training set with
confirmatory factor analysis (CFA), using Lisrel 8.5
(Scientific Software International, Lincolnwood, IL,
USA). We calculated χ2, Root Mean Square Error of
Approximation (RMSEA) and Comparative Fit Index (CFI)
to test the fit of the model, using Robust Maximum
Likelihood estimation. An acceptable model fit would be
indicated by χ2 of >0.05, RMSEA of <0.06 and CFI of
>0.95. Second, in case of unsatisfactory fit of the initial model
and item set, item reduction would be performed, based on
preliminary descriptive characteristics of all items. Items
deemed inadequate because of high rates of non-response,
low-item scale and test–retest correlations and high skewness
were removed. If two similar items had equivalent content and
psychometric properties, two authors (MH and ES) selected
the most appropriate alternative based on additional criteria,
i.e. avoiding confusing or lengthy wording, and patients'
additional comments indicating an item's relevance for trust.
Third, to examine alternative models of dimensionality,
exploratory factor analysis (EFA) was performed on the
training set, using the definitive item selection. Outcomes
were used to adapt the theoretical dimensional model. Based
on the EFA findings, CFA was performed to test the final
model, using the test set. Fourth, internal consistency of the
TiOS overall and its subscales was calculated using Crohn-
bach's α, within-item-variance and between-items-covariance.
Inter-item correlations between 0.10 and 0.50 were consid-
ered acceptable. Item-scale correlations should be >0.20.
Correlations between test and retest scores were calculated to
assess test–retest reliability. Both internal consistency and
test–retest reliability were expected to be high.
Construct validity was assessed by calculating Spear-
man's correlations between trust (TiOS) and satisfaction
(PSQ), trust in health care, willingness to recommend the
oncologist to others and number of previous consultations
with the oncologist. Moderately positive associations
between trust and these correlates would indicate good
construct validity [4, 9, 10, 28]. Exploratory analyses were
performed to assess Spearman's correlations between trust
and patients' age, gender, education, ethnicity, religion, time
since diagnosis and physical and mental health.
Results
Descriptives and missing data
Of all 675 patients who received the questionnaires, 506
(75%) responded, 70 (10%) of whom declined participa-
tion, resulting in a response rate of 65% (n=436). Most
frequent reasons to decline were (1) too much of a burden
(n=28), (2) not enough contact with the oncologist (n=12)
and (3) poor health (n=10).
Data of 13 participants with high rates of missing data
were completely excluded. For the remaining 0.74% of
missing data on the TiOS, EM was performed. Patients'
socio-demographic data are displayed in Table 1. The
Table 1 Demographic, health and relationship characteristics of the
sample (n=423)
Median (Range) SD






None/primary school 47 11












Time since diagnosis (n=422)
<1 month 5 1
1–6 months 77 18
6–24 months 148 35
>24 months 192 46
Specialist about whom reported (n=423)
Radiation oncologist 148 35
Medical oncologist 133 31
Surgeon/urologist 142 34









Number of consultations with present oncologist (n=419)
<3 Consultations 40 10
3–5 Consultations 112 27
6–10 Consultations 123 29
11–15 Consultations 57 14
>15 Consultations 87 21
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distribution was left-skewed, with high Kurtosis. Most
patients currently had one (45%) or two (36%) oncologists
presently involved in their cancer care. Regression analysis
indicated that the type of recruitment, i.e. by the researcher
or the oncologist explained no significant variation in trust
scores (0.8%, F(1, 421)=3.26, p=0.07).
Dimensionality and item reduction
Step 1 Confirmatory factor analysis of initial model
To address problems of under-identification due
to empty cells, response categories 1 (completely
disagree) and 2 (disagree) were collapsed, leaving
four Likert response categories. Our original
theoretically driven 5-factor model did not result
in a satisfactory model fit: Satorra-Bentler Scaled
χ2 (476, N=211)=1,283.81 (p<0.001), RMSEA=
0.09 and CFI=0.94.
Step 2 Item reduction and model adjustment
In total, 15 items were removed, resulting in a
definitive sample of 18 items, displayed in Table 2
along with their origin and psychometric proper-
ties. All three items of the ‘Confidentiality’
dimension were removed because of insufficient
psychometric quality, and because patients, in their
additional comments to the questionnaire, indicat-
ed these items to be irrelevant to trust. Conse-
quently, we re-specified our final model to be four-
dimensional (see Fig. 1). The mean overall trust
score for the definitive item set (TiOS) was 4.56
(SD=0.51, range 2.44–5.00).
Step 3 Exploratory factor analysis
EFA with direct oblimin rotation (Δ=0) was
conducted for the definitive set of items. Three
components were extracted with eigenvalues >1,
jointly explaining 61.51% of the variance. Item
loadings suggested that component 1, on which all
items loaded strongly, represented a general mea-
sure of ‘trust’ (eigenvalue=8.42). Component 2
comprehended negatively phrased items (eigenval-
ue=1.48), and component 3 was the least coherent,
containing a variety of items (eigenvalue=1.18).
These results suggest that meaningful dimensions
of trust could not be distinguished, and that a one-
dimensional model of trust might be the most
appropriate.
Step 4 Testing of definitive model
Based on the EFA outcomes, CFA was used to
test a one-dimensional model. This model did not
fit the data satisfactory (Satorra-Bentler Scaled χ2
(134, N=212)=210.64 (p<0.001), RMSEA=0.05
and CFI=0.93). Additionally, we tested our defin-
itive, theoretically driven 4-factor model (see
Fig. 1). This model fit the data reasonably well
(Satorra-Bentler Scaled χ2 (122, N=212)=154.58
(p=0.03), RMSEA=0.04 and CFI=0.95). Standard-
ized factor loadings of the items were adequate (see
Table 3). However, correlations between common
factors were extremely strong (see Table 4). This,
and issues indicating persistent multi-collinearity
encountered when running the model, suggest that
conceptually, a one-dimensional model best
explains our findings.
Reliability
Reliability of the TiOS overall was high (α=0.92) and
ranged from acceptable to good for the subscales: Compe-
tence (α=0.65), Fidelity (α=0.87), Honesty (α=0.75) and
Caring (α=0.73). Correlations between all four dimensions
and the two global validation items ranged from 0.48 to
0.67. Item–scale correlations ranged from 0.51 to 0.71.
Inter-item correlations were acceptable, ranging between
0.2 and 0.6, mostly. Test–retest reliability for the total score
was high, rs=0.93, and ranged between 0.43 and 0.92 for
individual items. We found equally high test–retest reliabil-
ity, ranging between 0.77 and 0.82, for all four dimensions
of the TiOS.
Validity
Good construct validity was indicated by significant
Spearman's correlations between overall trust and satis-
faction (rs (420)=0.63, p<0.001), willingness to recom-
mend the oncologist to others (rs (408)=0.62, p<0.001),
trust in healthcare (rs (423)=0.24, p<0.001) and number
of consultations (rs (419)=0.16, p<0.001) (see Table 5).
Exploratory analyses
Trust was significantly stronger among older patients
(rs (413)=0.10, p<0.05) and patients with better mental
health (rs (287)=0.17, p<0.01). Dutch patients (M=4.57,
SD=0.51) reported stronger trust than non-Dutch patients
(M=4.34, SD=0.49), F(421)=0.90, p<0.05. Correlations
between trust and all other exploratory variables were non-
significant (p>0.05).
Discussion
In this study, the TiOS, an 18-item questionnaire assessing
cancer patients' trust in their oncologist, was developed and
empirically validated. Our findings suggest that the TiOS
reliably and validly assesses cancer patients' trust in their
oncologist. In addition to the dimensions distinguished
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previously, i.e. Fidelity, Competence and Honesty, a new
dimension of cancer patients' trust, labelled ‘Caring’, was
distinguished and empirically validated in this study.
Internal consistency, test–retest reliability and construct
validity of the TiOS were good, as indicated by moderate
correlations between trust and satisfaction, willingness to
recommend the oncologist to others, trust in the health care
system and the number of consultations with the oncologist.
Exploratory analyses indicated higher trust among older,
Dutch patients with better mental health.
Dimensionality analyses lead us to conclude that at least
in this heterogeneous sample of cancer patients, trust is
very coherent and can therefore be regarded as one-
dimensional. At the same time, testing of our theoretical
model suggests that patients do distinguish between
different aspects contributing to trust, i.e. Competence,
Fidelity, Honesty and Caring. This distinction allows for
the separate use or investigation of one of these four
specific aspects of trust. Depending on the researcher's
aims, trust can therefore be represented and used both as a
broad, general construct or as a combination of separate
dimensions each representing an aspect of trust [29].
Possibly, multi-dimensionality is more pronounced among
cancer patients with stronger variations in trust levels, e.g.
in palliative care.
The skewed distribution of trust scores is in line with
findings in other populations [9, 10, 16, 17]. Indeed, the
high trust levels among cancer patients reported here
possibly even exceed trust levels reported in the primary
care setting [10, 14, 30]. Possibly, such strong trust is
induced by the life-threatening nature of cancer. Previous
qualitative findings indeed suggest that for these patients,
the need to trust their oncologist is strong [18]. Even in a
sub-optimal relation with the oncologist, patients might
Table 2 Overview of all items included in the TiOS, their source, dimension, mean, standard deviation, skewedness and item-scale correlation
Item Content Sourcea Dimension Mb SD Skewness Item-scale
correlation
1 Your doctor is very careful and precisec PTS Competence 4.65 0.67 −2.65 0.53
2 Your doctor is totally honest in telling you about all the different
treatment options available for your condition
PTS Honesty 4.68 0.63 −2.31 0.63
3 Your doctor always gives you honest information about your
prospects
New Honesty 4.58 0.77 −2.28 0.56
4 Your doctor strongly cares about your healthc IP PTS Fidelity 4.51 0.79 −1.97 0.69
5 Your doctor always tells you everything you want to know about
your illness
MISS Fidelity 4.63 0.72 −2.33 0.64
6 You think your doctor can handle any medical situation, even a
very serious onec
IP PTS Competence 4.53 0.76 −1.77 0.65
7 Your doctor always takes his/her time with you New Caring 4.61 0.70 −2.24 0.58
8 Your doctor explains everything so that you can consent to
medical decisions
New Fidelity 4.64 0.64 −2.04 0.71
9 Sometimes you worry that your doctor's medical decisions are
wrongd
IP PTS Competence 4.37 1.09 −1.87 0.54
10 Your doctor only thinks about what is best for you PTS Fidelity 4.62 0.69 −2.35 0.63
11 Sometimes your doctor does not pay full attention to what you
are trying to tell him/herd
PTS Competence 4.24 1.10 −1.48 0.61
12 Your doctor would always tell you the truth about your health,
even if there was bad newsc
PCAS Honesty 4.67 0.65 −2.65 0.51
13 You have doubts whether your doctor really cares about you as
a personc,d
TiPS Caring 4.47 0.98 −2.03 0.61
14 Your doctor listens with care and concern to all the problems
you havec
IP PTS Caring 4.57 0.72 −1.94 0.63
15 Your doctor will do whatever it takes to get you all the care
you need
PTS Fidelity 4.70 0.56 −1.87 0.75
16 Your doctor is available for you whenever you need him/her New Caring 4.46 0.78 −1.37 0.62
17 You have no worries about putting your life in your doctor's hands PTS Global item 4.39 0.99 −1.91 0.51
18 All in all, you have complete trust in your doctor PTS Global item 4.39 0.60 −2.21 0.72
aPTS Patient Trust Scale, IP PTS Item Pool for PTS, MISS Medical Interview Satisfaction Scale, PCAS Primary Care Assessment Survey, TiPS
Trust in Physician Scale
b Five-point likert scale: 1=totally disagree, 2=disagree, 3=as much agree as disagree, 4=agree, 5=strongly agree
cMinor modifications to original wording
d Reverse-scored items
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refrain from questioning their trust, thus preventing them
from experiencing cognitive dissonance that could arise
when they remain with an oncologist they do not trust
completely. Salmon and Young [31] suggest that patients
with more threatening diseases, such as cancer, might create
more positive images of their physicians, reasoning that
‘patients subjectively construct their image of the practi-
tioner to meet their own safety and dependency needs
and in line with their own mental models of self and other’
(p. 33). However, this theory is not completely in line with
our exploratory finding of stronger trust among patients
with better mental health. Research would need to confirm
Table 3 Confirmatory factor analysis of the 4-dimensional conceptual model for the TiOS: standardized factor loadings
Standardized factor loading
Item 1a 2 3 4
Your doctor is very careful and precise (item 1) 0.77
You think your doctor can handle any medical situation, even a very serious one (item 6) 0.80
Sometimes you worry that your doctor's medical decisions are wrong (item 9) 0.65
Sometimes your doctor does not pay full attention to what you are trying to tell him/her (item 11) 0.69
Your doctor strongly cares about your health (item 4) 0.85
Your doctor always tells you everything you want to know about your illness (item 5) 0.80
Your doctor explains everything so that you can consent to medical decisions (item 8) 0.87
Your doctor only thinks about what is best for you (item 10) 0.83
Your doctor will do whatever it takes to get you all the care you need (item 15) 0.93
Your doctor is totally honest in telling you about all the different treatment options available for your
condition (item 2)
0.87
Your doctor always gives you honest information about your prospects (item 3) 0.87
Your doctor would always tell you the truth about your health, even if there was bad news (item 12) 0.72
Your doctor always takes his/her time with you (item 7) 0.83
You have doubts whether your doctor really cares about you as a person (item 13) 0.66
Your doctor listens with care and concern to all the problems you have (item 14) 0.86
Your doctor is available for you whenever you need him/her (item 16) 0.84
aFactor 1 Competence, factor 2 Fidelity, factor 3 Honesty, factor 4 Caring
Fig. 1 Final measurement
model of the definitive four-
dimensional theoretical model
tested in confirmatory factor
analysis. Items 17 and 18 are
modelled as single indicator
exogenous variables. Asterisk
represents all possible correla-
tions between item 17 and item
18 and the common factors
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whether trust levels are indeed higher for patients with
severe conditions like cancer by comparing different patient
populations and with varying health status.
The finding that trust is less strong among patients with
non-Dutch ethnicities has been reported previously, both in
primary care and in the oncology setting [28, 30, 32–34].
Previous studies were mostly performed in the USA, and
report lower trust among African American than among
Caucasian patients. In the present study, trust was lower
among non-Dutch patients from both Western and non-
Western countries. However, the relative scarcity of non-
Dutch patients in our sample and the exploratory nature of
this analysis warrant further investigation of the relation-
ship between trust and ethnicity. Such research should
preferably not only focus on trust levels, but also on
differences in constructions and explanations of trust.
The skewed distribution of trust scores raises the
question whether these high scores accurately reflect very
strong levels of trust or result from a measurement
limitation. It would be worthwhile to first investigate
whether, among specific groups of cancer patients, TiOS
scores are less skewed. Such research could be conducted
in samples where lower trust might reasonably be expected,
e.g. immigrants or patients requesting second opinions. A
lack of more variability in TiOS scores among such
samples would warrant further explorations of possibly
more sensitive research methods. More variability in trust
levels could possibly be registered with different item
wordings or other response formats (e.g. asymmetric
answer formats). Alternatively, researchers might resort to
different methods, such as unobtrusive measures, in order
to avoid patients' conscious processes and cognitions [35].
Presently, the quantitative, self-report, nature of the TiOS
prohibits conclusions about patients' underlying processes
during questionnaire completion. As such, the TiOS might
be assessing patients' determination to trust the oncologist,
rather than their actual basic trust.
In addition to these considerations about skewness, this
study has some limitations. First, although construct
validity of the TiOS was addressed, more research would
be needed to assess how TiOS scores relate to relevant
clinical and/or patient-reported outcomes, thus establishing
predictive validity. Second, the TiOS was presently only
validated in a sample of Dutch cancer patients. Further
validation should include administration of the scale among
patients in other countries. A final important consideration
is the scope of the questionnaire. As the oncology setting is
becoming increasingly multidisciplinary, patients are con-
fronted with treatment by an interdisciplinary team of
health care professionals. The oncologist is no longer by
definition the central carer. Indeed, in patients' perceptions,
there might not be a central care provider at all [36].
Patients' additional comments in the survey suggest that,
consequently, some patients find it easier to report on the
care delivered by the entire team, than by the oncologist
specifically. It is worth investigating whether and how
increased multi-disciplinarity in oncology care impacts on
patients' interpersonal and more general trust.
In conclusion, the current study has contributed to the
study of cancer patients' trust in their oncologist by
enabling the accurate assessment of trust in the cancer
patient population. We think that the TiOS improves further
Table 4 Confirmatory factor
analysis of the four-dimensional
conceptual model for the TiOS:
common factor loadings
Factor






Honesty 0.96 0.88 1
Caring 0.91 0.98 0.76 1
Global 1 (item 17) 0.86 0.78 0.80 0.74 1
Global 2 (item 18) 0.93 0.92 0.82 0.92 0.85 1
Table 5 Construct validity of the
TiOS: means, standard deviations
and Spearman's correlation of
physician satisfaction, willingness
to recommend, trust in health care
and number of consultations with
overall TiOS score
aSignificant at the 0.001 level
Measure (possible range) M SD rs
Trust in oncologist (1–5) 4.56 0.51
Satisfaction with oncologist (0–500) 407 74 0.63a
Trust in healthcare (1–5) 3.93 0.77 0.24a
Willingness to recommend oncologist (1–5) 4.64 0.67 0.62a
Number of physician consultations 3.09 1.27 0.16a
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expansion of this field of study, resulting in better insight
into the nature, predictors and consequences of these
patients' trust, which could ultimately improve patient care.
Acknowledgements We would like to acknowledge all the physicians
of the Departments of Clinical Oncology, Radiation Oncology and
Surgery, as well as the nurses of the Department of Surgery at the AMC
and Mariëtte Weterman for their assistance in the recruitment of patients.
We are grateful to Phyllis Butow for her constructive comments during
the analysis and reporting phase. This study was supported by the Dutch
Cancer Society [grant number: UVA 2008-4015].
Open Access This article is distributed under the terms of the
Creative Commons Attribution Noncommercial License which per-
mits any noncommercial use, distribution, and reproduction in any
medium, provided the original author(s) and source are credited.
References
1. Mechanic D, Meyer S (2000) Concepts of trust among patients
with serious illness. Soc Sci Med 51(5):657–668
2. Goudge J, Gilson L (2005) How can trust be investigated?
Drawing lessons from past experience. Soc Sci Med 61:1439–
1451
3. McKinstry B, Ashcroft RE, Car J, Freeman GK, Sheikh A (2006)
Interventions for improving patients' trust in doctors and groups of
doctors. Cochrane Database Syst Rev 3: Art. No.: CD004134
4. Hall MA, Dugan E, Zheng BY, Mishra AK (2001) Trust in
physicians and medical institutions: what is it, can it be measured,
and does it matter? Milbank Q 79(4):613–639
5. Baier A (1986) Trust and antitrust. Ethics 96:231–260
6. Goold SD (2002) Trust, distrust and trustworthiness. J Gen Intern
Med 17(1):79–81
7. Pearson SD, Raeke LH (2000) Patients' trust in physicians: many
theories, few measures, and little data. J Gen Intern Med 15
(7):509–513
8. Seetharamu N, Iqbal U,Weiner JS (2007) Determinants of trust in the
patient-oncologist relationship. Palliat Support Care 5(4):405–409
9. Thom DH, Ribisl KM, Stewart AL, Luke DA (1999) Further
validation and reliability testing of the Trust in Physician Scale.
Med Care 37(5):510–517
10. Hall MA, Zheng BY, Dugan E et al (2002) Measuring patients'
trust in their primary care providers. Med Care Res Rev 59
(3):293–318
11. Trachtenberg F, Dugan E, Hall MA (2005) How patients' trust relates
to their involvement in medical care. J Fam Pract 54(4):344–352
12. Safran DG, Taira DA, Rogers WH et al (1998) Linking primary
care performance to outcomes of care. J Fam Pract 47(3):213–220
13. O'Malley AS, Sheppard VB, Schwartz M, Mandelblatt J (2004)
The role of trust in use of preventive services among low-income
African-American women. Prev Med 38(6):777–785
14. Balkrishnan R, Dugan E, Camacho FT, Hall MA (2003) Trust and
satisfaction with physicians, insurers, and the medical profession.
Med Care 41(9):1058–1064
15. Hillen MA, de Haes HC, Smets EM (2011) Cancer patients' trust
in their physician—a review. Psychooncology 20:227–241
16. Anderson AA, Dedrick FD (1990) Development of the trust in
physician scale: a measure to assess interpersonal trust in patient–
physician relationships. Psychol Rep 67:1091–1100
17. Kao AC, Green DC, Zaslavsky AM, Koplan JP, Cleary PD (1998)
The relationship between method of physician payment and
patient trust. JAMA 280(19):1708–1714
18. Hillen MA, Onderwater AT, Van Zwieten MCB, de Haes JC,
Smets EM (2011) Disentangling cancer patients’ trust in their
oncologist: a qualitative study. Psychooncology (in press)
19. Wolf MH, Putnam SM, James SA, Stiles WB (1978) The medical
interview satisfaction scale: development of a scale to measure
patient perceptions of physician behavior. J Behav Med 1(4):391–
401
20. Safran DG, Kosinski M, Tarlov AR et al (1998) The primary care
assessment survey—tests of data quality and measurement
performance. Med Care 36(5):728–739
21. Oosterveld P, Vorst HCM (1998) Constructie van meetinstru-
menten. Testleer en testconstructie, In: Van Den Brink WP and
Mellenbergh GJ (Eds), Amsterdam, Boom pp 305–337
22. Willis G (1999) Cognitive Interviewing. A ‘How To’ Guide.
Research Triangle Park, NC, Research Triangle Institute
23. Tabachnick BG, Fidell LS (2001) Using multivariate statistics, 4th
edn. Boston, Allyn and Bacon
24. Ong LML, Visser MRM, Lammes FB, de Haes JCJM (2000)
Doctor-patient communication and cancer patients' quality of life
and satisfaction. Patient Educ Couns 41:145–156
25. Gandek B, Ware JE, Aaronson NK et al (1998) Cross-validation
of item selection and scoring for the SF-12 Health Survey in nine
countries: results from the IQOLA Project. J Clin Epidemiol 51
(11):1171–1178
26. Ware JE, Kosinski M, Keller SD (1996) A 12-item Short-Form
Health Survey: construction of scales and preliminary test of
reliability and validity. Med Care 34:220–226
27. Tabachnick BG, Fidell LS (2000) Cleaning up your act: screening
data prior to analysis. In Using multivariate statistics, 4th ed.
Allyn and Bacon pp 56–110
28. Carpenter WR, Godley PA, Clark JA et al (2009) Racial
differences in trust and regular source of patient care and the
implications for prostate cancer screening use. Cancer 115
(21):5048–5059
29. Marshall GN, Hays RD, Sherbourne CD, Wells KD (1993) The
structure of patient satisfaction with outpatient medical care.
Psychol Assess 5(4):477–483
30. Doescher MP, Saver BG, Franks P, Fiscella K (2000) Racial and
ethnic disparities in perceptions of physician style and trust. Arch
Fam Med 9:1156–1163
31. Salmon P, Young B (2009) Dependence and caring in clinical
communication: the relevance of attachment and other theories.
Patient Educ Couns 74(3):331–338
32. Berrios-Rivera JP, Street RL, Popa-Lisseanu MGG et al (2006)
Trust in physicians and elements of the medical interaction in
patients with rheumatoid arthritis and systemic lupus erythemato-
sus. Arthritis Rheum 55(3):385–393
33. Boulware LE, Cooper LA, Ratner LE, LaVeist TA, Powe NR
(2003) Race and trust in the health care system. Public Health Rep
118:358–365
34. Gordon HS, Street RL Jr, Sharf BF, Kelly PA, Souchek J (2006)
Racial differences in trust and lung cancer patients' perceptions of
physician communication. J Clin Oncol 24(6):904–909
35. De Houwer J, Teige-Mocigemba S, Spruyt A, Moors A (2009)
Implicit measures: a normative analysis and review. Psychol Bull
135(3):347–368
36. Epner DE, Ravi V, Baile WF (2010) “When patients and families
feel abandoned”. Support Care Cancer doi:10.1007/s00520-010-
1007-6
Support Care Cancer (2012) 20:1787–1795 1795
